Simplex Trading
BVS icon

Simplex Trading’s Bioventus BVS Stock Holding History

Simplex Trading’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-21,180
Closed -$212K – 8584
2024
Q4 		$222K Buy
21,180
+20,491
+2,974% +$242K ﹤0.01% 4409
2024
Q3 		$8K Sell
689
-12,694
-95% -$110K ﹤0.01% 7307
2024
Q2 		$76K Buy
13,383
+12,105
+947% +$66.4K ﹤0.01% 5656
2024
Q1 		$6K Sell
1,278
-13,269
-91% -$64.8K ﹤0.01% 7893
2023
Q4 		$76K Buy
14,547
+6,319
+77% +$25K ﹤0.01% 5646
2023
Q3 		$27K Buy
+8,228
New +$28.9K ﹤0.01% 6342
2023
Q2 		– Sell
-6,848
Closed -$13.1K – 9009
2023
Q1 		$7K Buy
6,848
+5,972
+682% +$11.4K ﹤0.01% 7796
2022
Q4 		$2K Buy
876
+454
+108% +$1.98K ﹤0.01% 8532
2022
Q3 		$2K Buy
422
+351
+494% +$2.75K ﹤0.01% 9240
2022
Q2 		$0 Buy
71
+30
+73% +$306 ﹤0.01% 10001
2022
Q1 		$0 Buy
+41
New +$549 ﹤0.01% 10426

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Simplex Trading's BVS Position: Q1 2025 in Review

Simplex Trading sold out of Bioventus (BVS) in Q1 2025, closing a stake of 21,180 shares — an estimated $212K sold.

Simplex Trading first reported a position in BVS in Q1 2022 and held it in 11 quarters. The position peaked at $222K in Q4 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Simplex Trading reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 21,180 Bioventus shares in Q1 2025, an estimated $212K.
  • Simplex Trading first reported a position in Bioventus in Q1 2022 and held it in 11 quarters.
  • Simplex Trading's Bioventus position peaked at $222K in Q4 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.